Shimadzu Medical Systems USA has announced that its Dallas-headquartered direct sales and service division has expanded its territory to include the western half of the state of Arkansas.
Researchers have announced the results of a study that used speckle-tracking echocardiography (STE) to analyze early phase one results from the multi-center COMPASSION trial, which seeks to examine the safety and efficacy of a new option to replace dysfunctional pulmonary valves in a subset of congenital heart disease patients.
June 23, 2014 — Researchers have announced the results of a study that used contrast ultrasound molecular imaging (CMI) to examine a relatively new role for platelets at early to mid stages of atherosclerosis. Atherosclerosis, or hardening of the arteries due to plaque buildup, can lead to many serious health problems, including stroke and coronary heart disease.
eHealth Saskatchewan plays a vital role in providing IT services to patients, health care providers, and partners such ...
June 23, 2014 — Researchers have announced the results of a four-year study that used 3-D echocardiography to examine the role of mid left atrial cross sectional area (LACSA) as a risk factor for cardioembolic (CE) stroke, atrial fibrillation (AF) and stroke recurrence.
DAIC Editor Dave Fornell shares his choices for the most innovative new technologies in nuclear imaging that were on ...
Mobius Imaging LLC received two prestigious and internationally recognized honors for its AIRO Mobile Intraoperative CT (computed tomography) system: a 2014 Red Dot Product Design Award and selection as a finalist in 17th annual Medical Design Excellence Awards competition.
While most women understand the importance of health screenings, an estimated 72 million have missed or postponed a ...
Oxford University researchers funded by Parkinson's UK have developed a simple and quick magnetic resonance imaging (MRI) technique that offers promise for early diagnosis of Parkinson's disease.
The doctors and staff of the Indiana University Health Proton Therapy Center in Bloomington, Ind., have collaborated with Indy Composite Works (ICW) to design and manufacture a customized carbon fiber patient treatment table that has significantly improved the flexibility and precision of proton therapy while increasing patient comfort.
A simple noninvasive blood test matched with state-of-the-art molecular imaging of individual cells could help oncologists understand their patients’ chances of survival, said researchers at the 2014 annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI).
Fujifilm’s APERTO Lucent is a 0.4T mid-field, open MRI system addressing today’s capability and image quality needs ...
Bayer HealthCare announced the U.S. Food and Drug Administration (FDA) approved a new indication for Gadavist (gadobutrol) injection for intravenous use with magnetic resonance imaging (MRI) of the breast to assess the presence and extent of malignant breast disease. The approval is based on priority review of two multicenter, Phase III studies (GEMMA-1 and GEMMA-2) conducted in 13 countries.
Patients with advanced breast cancer that may have spread to their lymph nodes could benefit from a more robust dose of a molecular imaging agent called Tc-99m filtered sulfur colloid when undergoing lymphoscintigraphy, a functional imaging technique that scouts new cancer as it begins to metastasize. Best results also indicate that imaging could be improved by injecting the agent the day prior to surgical resection, according to research unveiled at the 2014 annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI).
There were several interesting studies coming out of the 2014 meeting for the Society of Nuclear Medicine and Molecular Imaging (SNMMI) in St. Louis, Mo. On the show floor, the main news was that all the key vendors introduced new PET/CT systems for the market.
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
Satoshi Minoshima, M.D., Ph.D., chairman of the Society of Nuclear Medicine and Molecular Imaging Scientific Committee ...
Elekta and Royal Philips announced that The Institute of Cancer Research, London, a world-leading cancer research institution, working with its clinical partner The Royal Marsden NHS Foundation Trust, will join the Elekta MR Linac Research Consortium, a group with a mission to develop an integrated magnetic resonance imaging (MRI)-guided radiation therapy system.
A simple noninvasive blood test matched with state-of-the-art molecular imaging of individual cells could help oncologists understand their patients’ chances of survival, said researchers at the Society of Nuclear Medicine and Molecular Imaging’s 2014 Annual Meeting (SNMMI).
June 18, 2014 — Researchers at Sandia National Laboratories, along with collaborators from Rice University and the Tokyo Institute of Technology, are developing new terahertz detectors based on carbon nanotubes that could lead to significant improvements in medical imaging, airport passenger screening, food inspection and other applications.
June 18, 2014 — A new molecular imaging agent has been developed to help clinicians find as much cancer as possible, whether it is responding favorably or not, in an effort to improve clinical decision making for prostate cancer patients, said researchers at the 2014 annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI).
June 17, 2014 — Navidea Biopharmaceuticals Inc. announced results from a post-hoc analysis of patient data from the company’s phase III clinical trial (NEO3-06) of Lymphoseek in head and neck cancer.
June 17, 2014 — A total of 16 pioneering medical innovations were showcased in front of approximately 4,000 healthcare providers and experts at Premier Inc.'s sixth annual Innovation Celebration, such as the world's first and only intravenous implantable cardiac defibrillator (ICD).
June 16, 2014 — Piramal Imaging released details from research presented at the 2014 annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) in St. Louis. Research findings relating to the development and approval of Neuraceq (florbetaben F18 injection) were presented during the AD II: Advanced Approaches Session.